Dr. Nino Aleksidze, MD
- Medicare services, 2024
- 9,071
- Medicare patients, 2024
- 173
- Part D claims, 2024
- 2,027
- MIPS score, 2024
- 94
- Hospital affiliations
- 3
- Practice address
- 2105 East South Boulevard, Montgomery, AL 36116
- Practice phone
- Call (334) 288-2100
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Aleksidze's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Nino Aleksidze is a hematologist and oncologist in Montgomery, Alabama
Dr. Aleksidze practices at Baptist Medical Center South in Montgomery, Alabama, part of University of Alabama at Birmingham.
Dr. Aleksidze's NPI, 1427438530, was assigned on June 3, 2015. Dr. Aleksidze holds Alabama license 42597.
- NPI
- 1427438530NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4284034463
- NPI enumeration date
- June 3, 2015
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (334) 288-2100
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 42
- Medical school graduation
- 2010
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Nino Aleksidze practices at Baptist Medical Center South in Montgomery, Alabama
Dr. Aleksidze's primary practice is Baptist Medical Center South, at 2105 East South Boulevard, Montgomery, AL 36116 in Montgomery County. The practice phone is (334) 288-2100.
- Baptist Medical Center South2105 East South Boulevard, Montgomery, AL 36116 · Montgomery CountyPhone(334) 288-2100
Source: Dmand AI Affiliation Data
Dr. Nino Aleksidze is affiliated with 8 sites of care and 4 medical groups
Dr. Aleksidze's primary practice is Baptist Medical Center South in Montgomery, Alabama, part of University of Alabama at Birmingham. Dr. Aleksidze is also affiliated with Baptist Medical Center East. The medical group on file is Montgomery Cardiovascular Associates, P.C. Dmand AI also links Dr. Aleksidze to 1 more hospital, 4 group practices and clinics, 3 medical groups and 1 hospice, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Nino Aleksidze's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aleksidze practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Baptist Medical Center South | Available with a free account |
| +7 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Alabama at Birmingham and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Nino Aleksidze is one of 169 hematologists and oncologists in Alabama
Hematology and oncology is Dr. Aleksidze's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Aleksidze is licensed in Alabama.
Specialties and state licenses
- Hematology and oncology, AlabamaPrimary
Hematologists and oncologists near Dr. Aleksidze
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Nino Aleksidze billed Medicare for 9,071 services in 2024
CMS data shows 9,071 Medicare services from Dr. Aleksidze across 23 procedure codes in 2024, for 173 Medicare patients. Medicare paid $156,361 for them.
Dr. Aleksidze's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 5,2302024: 7,52744%
- Tests and treatments
- 2023: 5672024: 78939%
- Office and hospital visits
- 2023: 2712024: 568110%
- Surgery
- 2023: 1372024: 18736%
Where Dr. Aleksidze's Medicare services took place, 2024
- In an office9,056100%
- In a facility150%
Dr. Aleksidze compared with the Alabama median for hematologists and oncologists, 2024
- Dr. Aleksidze
- Alabama median
- Medicare services
- 9,071vs 1,2247.4 times
- Medicare patients
- 173vs 28239% below
- Part D claims
- 1,617vs 84691% above
Medians across 162 hematologists and oncologists in Alabama with Dmand AI profiles that report each measure.
Dr. Aleksidze's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Aleksidze?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Aleksidze and other hematologists and oncologists in Alabama.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Nino Aleksidze treated 173 Medicare patients in 2024, average age 73
CMS counts 173 Medicare patients who saw Dr. Aleksidze in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Aleksidze's median patient age at 68, with 62% women.
Dr. Aleksidze's Medicare patients by age, 2024
Dr. Aleksidze's Medicare patients by sex, 2024
- Women10661%
- Men6739%
Chronic conditions among Dr. Aleksidze's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis55%
- Cancer43%
- Diabetes43%
- Ischemic heart disease39%
- Chronic kidney disease33%
- Anxiety31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Aleksidze's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women62%
- Men38%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Nino Aleksidze wrote 2,027 Medicare Part D claims in 2024
In 2024, Dr. Aleksidze wrote 2,027 Medicare Part D claims for 238 patients. 58% of them were for generic drugs. CMS names the drug for 1,617 of them, across 50 drugs with 11 or more claims each, at $5,295,020 in total drug cost. In 2023, CMS named 901 claims across 33 drugs.
Dr. Aleksidze's Part D claims by kind of drug, 2024
- Generic1,184 claims58%
- Brand-name843 claims42%
Dr. Aleksidze's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Aleksidze's Part D claims, 2024
- Opioids7%144 of 2,027 claims
- Antibiotics3%65 of 2,027 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 9012024: 1,61779%
Drugs named by CMS: 50 in 2024, 33 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Nino Aleksidze scored 94 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Aleksidze for performance year 2024, reported as part of a group. Dr. Aleksidze accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Aleksidze's MIPS scores, performance year 2024
- 94of 100Final score
- 79of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 86of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Nino Aleksidze received $5,120 in industry payments from 2016 to 2025
CMS Open Payments shows 244 general payments to Dr. Aleksidze from 52 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Celgene Corporation paid the most, $642.
General payments to Dr. Aleksidze by program year, 2016 to 2025
General payments to Dr. Aleksidze by kind, 2016 to 2025
- Food and beverage$4,63991%
- Education$4819%
Companies that paid Dr. Aleksidze the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Nino Aleksidze's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Nino Aleksidze
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Nino Aleksidze's NPI number?
Dr. Nino Aleksidze's NPI number is 1427438530. It was assigned on June 3, 2015, and it is active in the NPI Registry.
What kind of doctor is Dr. Nino Aleksidze?
Dr. Nino Aleksidze is a hematologist and oncologist in Montgomery, Alabama. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Nino Aleksidze practice?
Dr. Aleksidze practices at 2105 East South Boulevard, Montgomery, AL 36116. Dr. Aleksidze's primary practice is Baptist Medical Center South in Montgomery, Alabama, part of University of Alabama at Birmingham. Dmand AI also links Dr. Aleksidze to 1 hospital, 4 group practices and clinics, 3 medical groups and 1 hospice.
What is Dr. Nino Aleksidze's office phone number?
The practice phone on file for Dr. Aleksidze is (334) 288-2100.
What is Dr. Nino Aleksidze's medical license number?
Dr. Aleksidze holds Alabama license 42597.
Which hospitals is Dr. Nino Aleksidze affiliated with?
Dr. Aleksidze practices at Baptist Medical Center South in Montgomery, Alabama. Dr. Aleksidze is also affiliated with Baptist Medical Center East. Dmand AI links Dr. Aleksidze to 1 more hospital.
What medical group is Dr. Nino Aleksidze part of?
Dr. Aleksidze is linked to Montgomery Cardiovascular Associates, P.C. Dmand AI links Dr. Aleksidze to 3 more medical groups.
Does Dr. Nino Aleksidze accept Medicare?
Yes. CMS data shows Dr. Aleksidze billed Medicare for 9,071 services in 2024, and Dr. Aleksidze accepts Medicare assignment.
What is Dr. Nino Aleksidze's MIPS score?
Dr. Aleksidze's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.
How many Medicare patients does Dr. Nino Aleksidze see?
CMS counts 173 Medicare patients who saw Dr. Aleksidze in 2024, with an average age of 73.
Show 4 more questionsShow fewer questions
What services does Dr. Nino Aleksidze bill to Medicare?
In 2024, Dr. Aleksidze's most billed Medicare services were injected or infused drug (J0897), injected or infused drug (J1100) and injected or infused drug (J1437).
What drugs does Dr. Nino Aleksidze prescribe most?
In 2024 Medicare Part D data, Dr. Aleksidze's most prescribed drugs by claims were Xgeva, Fosaprepitant Dimeglumine and Ondansetron ODT.
Has Dr. Nino Aleksidze received payments from drug or device companies?
CMS Open Payments shows $5,120 in general payments to Dr. Aleksidze from 52 companies from 2016 to 2025. The largest total came from Celgene Corporation.
How long has Dr. Nino Aleksidze been practicing?
Dr. Aleksidze graduated from medical school in 2010, 16 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in Alabama by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card